Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 03 Mar 2026 for AbbVie Inc., €3.2M. Read the official filing
Filing timeline
BuySaleAzita Saleki-Gerhardt
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Azita Saleki-Gerhardt: trading record in brief
Filings by Azita Saleki-Gerhardt span 2 companies, the busiest being AbbVie Inc. and Entegris Inc. In total, 33 filings cover trades dated from 5 February 2016 to 27 February 2026.
No open-market purchase appears, only 2 sales worth €3.5M. Besides market trades, the filings include 25 share grants and 5 option exercises.
The latest filing, published on 3 March 2026, reports a share grant of €3.2M in AbbVie Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Azita Saleki-Gerhardt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
16,309 shares@ US$232.0811.4% of flowCommon Stock, $0.01 par valueSEC:0001563545-26-000004:0
17,041 shares0Common Stock, $0.01 par valueSEC:0001563545-26-000002:0
42,370 shares@ US$54.868.0% of flowCommon Stock, $0.01 par valueSEC:0001415889-25-021944:0
2,897 shares0Common StockSEC:0001101302-25-000050:0
17,056 shares@ US$205.0214.4% of flowCommon Stock, $0.01 par valueSEC:0001415889-25-006581:0
17,986 shares0Common Stock, $0.01 par valueSEC:0001415889-25-004460:0
7,378 shares0Common Stock, $0.01 par valueSEC:0001415889-25-004460:1
6,060 shares0Common Stock, $0.01 par valueSEC:0001415889-25-004460:2
7,074 shares0Common Stock, $0.01 par valueSEC:0001415889-25-004460:3
25,630 shares0Common Stock, $0.01 par valueSEC:0001415889-24-024096:0
1,643 shares0Common StockSEC:0001101302-24-000033:0
23,966 shares@ US$178.9917.0% of flowCommon Stock, $0.01 par valueSEC:0001415889-24-006160:0
52,870 shares@ US$58.8812.4% of flowCommon Stock, $0.01 par valueSEC:0001415889-24-005065:0
32,097 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004426:0
8,558 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004426:1
7,380 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004426:2
6,060 shares0Common Stock, $0.01 par valueSEC:0001415889-24-004426:3
2,849 shares0Common StockSEC:0001101302-23-000061:0
33,359 shares@ US$154.2820.8% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-003851:0
25,000 shares@ US$51.425.2% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-002945:4
14,246 shares@ US$149.138.5% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-002945:5
10,754 shares@ US$150.056.5% of flowCommon Stock, $0.01 par valueSEC:0001415889-23-002945:6
48,127 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002945:0
11,229 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002945:1
8,560 shares0Common Stock, $0.01 par valueSEC:0001415889-23-002945:2
25 of 33 declarations
